{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T02:42:39Z","timestamp":1761619359880},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,8,28]],"date-time":"2010-08-28T00:00:00Z","timestamp":1282953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10096-010-1034-8","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T11:29:47Z","timestamp":1282908587000},"page":"1525-1532","source":"Crossref","is-referenced-by-count":14,"title":["Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii"],"prefix":"10.1007","volume":"29","author":[{"given":"F. E. S.","family":"Mendes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. V. N.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. S.","family":"Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. G.","family":"Alvarenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. P.","family":"Taborda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. M.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. S.","family":"Cisalpino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,28]]},"reference":[{"key":"1034_CR1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/432073","volume":"192","author":"AE Brouwer","year":"2005","unstructured":"Brouwer AE, Teparrukkul P, Pinpraphaporn S, Larsen RA, Chierakul W, Peacock S, Day N, White NJ, Harrison TS (2005) Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitis. J Infect Dis 192:681\u2013684","journal-title":"J Infect Dis"},{"key":"1034_CR2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/IAI.01119-08","volume":"77","author":"KL Mershon","year":"2009","unstructured":"Mershon KL, Vasuthasawat A, Lawson GW, Morrison SL, Beenhouwer DO (2009) Role of complement in protection against Cryptococcus gattii infection. Infect Immun 77:1061\u20131070","journal-title":"Infect Immun"},{"key":"1034_CR3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1128\/IAI.74.2.896-903.2006","volume":"74","author":"N Jain","year":"2006","unstructured":"Jain N, Li L, McFadden DC, Banarjee U, Wang X, Cook E, Fries BC (2006) Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system. Infect Immun 74:896\u2013903","journal-title":"Infect Immun"},{"key":"1034_CR4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1469-0691.2008.02021.x","volume":"14","author":"A Gomez-Lopez","year":"2008","unstructured":"Gomez-Lopez A, Zaragoza O, Dos Anjos Martins M, Melhem MC, Rodriguez-Tudela JL, Cuenca-Estrella M (2008) In vitro susceptibility of Cryptococcus gattii clinical isolates. Clin Microbiol Infect 14:727\u2013730","journal-title":"Clin Microbiol Infect"},{"key":"1034_CR5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijantimicag.2008.11.007","volume":"33","author":"ZU Khan","year":"2009","unstructured":"Khan ZU, Randhawa HS, Chehadeh W, Chowdhary A, Kowshik T, Chandy R (2009) Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole. Int J Antimicrob Agents 33:559\u2013563","journal-title":"Int J Antimicrob Agents"},{"key":"1034_CR6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jchromb.2007.01.012","volume":"852","author":"SS Kim","year":"2007","unstructured":"Kim SS, Im HT, Kang IM, Lee HS, Lee HW, Cho SH, Kim JB, Lee KT (2007) An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study. J Chromatogr B 852:174\u2013179","journal-title":"J Chromatogr B"},{"key":"1034_CR7","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/AAC.40.8.1935","volume":"40","author":"CH Koks","year":"1996","unstructured":"Koks CH, Meenhorst PL, Hillebrand MJ, Bult A, Beijnen JH (1996) Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules. Antimicrob Agents Chemother 40:1935\u20131937","journal-title":"Antimicrob Agents Chemother"},{"key":"1034_CR8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1128\/AAC.33.5.714","volume":"33","author":"SC Harris","year":"1989","unstructured":"Harris SC, Wallace JE, Foulds G, Rinaldi MG (1989) Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection. Antimicrob Agents Chemother 33:714\u2013716","journal-title":"Antimicrob Agents Chemother"},{"key":"1034_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2004.09.013","volume":"288","author":"V Porta","year":"2005","unstructured":"Porta V, Chang KH, Storpirtis S (2005) Evaluation of the bioequivalence of capsules containing 150\u00a0mg of fluconazole. Int J Pharm 288:81\u201386","journal-title":"Int J Pharm"},{"key":"1034_CR10","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1128\/AAC.48.3.985-991.2004","volume":"48","author":"RA Larsen","year":"2004","unstructured":"Larsen RA, Bauer M, Thomas AM, Graybill JR (2004) Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis. Antimicrob Agents Chemother 48:985\u2013991","journal-title":"Antimicrob Agents Chemother"},{"key":"1034_CR11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1439-0507.2007.01325.x","volume":"50","author":"DA Santos","year":"2007","unstructured":"Santos DA, Hamdan JS (2007) In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole. Mycoses 50:286\u2013289","journal-title":"Mycoses"},{"key":"1034_CR12","first-page":"133","volume":"19","author":"M Cuenca-Estrella","year":"2002","unstructured":"Cuenca-Estrella M, Rodriguez-Tudela JL (2002) Should antifungal treatments be based upon results of antifungal susceptibility testing? Rev Iberoam Micol 19:133\u2013138","journal-title":"Rev Iberoam Micol"},{"key":"1034_CR13","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2002) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M27-A2. CLSI, Wayne, PA"},{"key":"1034_CR14","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1128\/AAC.49.8.3297-3301.2005","volume":"49","author":"RA Larsen","year":"2005","unstructured":"Larsen RA, Bauer M, Thomas AM, Sanchez A, Citron D, Rathbun M, Harrison TS (2005) Correspondence of in vitro and in vivo fluconazole dose-response curves for Cryptococcus neoformans. Antimicrob Agents Chemother 49:3297\u20133301","journal-title":"Antimicrob Agents Chemother"},{"key":"1034_CR15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10096-004-1108-6","volume":"23","author":"AH Groll","year":"2004","unstructured":"Groll AH, Kolve H (2004) Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy. Eur J Clin Microbiol Infect Dis 23:256\u2013270","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1034_CR16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1130-1406(08)70057-3","volume":"31","author":"BM Soares","year":"2008","unstructured":"Soares BM, Santos DA, Kohler LM, da Costa C\u00e9sar G, de Carvalho IR, dos Anjos Martins M, Cisalpino PS (2008) Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing. Rev Iberoam Micol 31:242\u2013245","journal-title":"Rev Iberoam Micol"},{"key":"1034_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11046-007-9027-6","volume":"164","author":"VT Figueiredo","year":"2007","unstructured":"Figueiredo VT, de Assis Santos D, Resende MA, Hamdan JS (2007) Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections. Mycopathologia 164:27\u201333","journal-title":"Mycopathologia"},{"key":"1034_CR18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/jac\/43.6.817","volume":"43","author":"O Lortholary","year":"1999","unstructured":"Lortholary O, Nicolas M, Soreda S, Improvisi L, Ronin O, Petitjean O, Dupont B, Tod M, Dromer F (1999) Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timing. J Antimicrob Chemother 43:817\u2013824","journal-title":"J Antimicrob Chemother"},{"key":"1034_CR19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jpba.2005.07.020","volume":"40","author":"HRN Salgado","year":"2006","unstructured":"Salgado HRN, Lopes CCGO, Lucchesi MBB (2006) Microbiological assay for gatifloxacin in pharmaceutical formulations. J Pharm Biomed Anal 40:443\u2013446","journal-title":"J Pharm Biomed Anal"},{"key":"1034_CR20","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jaoac\/92.4.1076","volume":"92","author":"PMA Lima","year":"2009","unstructured":"Lima PMA, Prado ND, Silva MLM, Diniz RDL, Queiroz KM, C\u00e9sar Ida C, Pianetti GA, Santos DA (2009) Determination of ketoconazole in capsules by high-performance liquid chromatography and microbiological assay. J AOAC Int 92:1076\u20131081","journal-title":"J AOAC Int"},{"key":"1034_CR21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/AAC.42.3.528","volume":"42","author":"DM Diamond","year":"1998","unstructured":"Diamond DM, Bauer M, Daniel BE, Leal MAE, Johnson D, Williams BK, Thomas AM, Ding JC, Najvar L, Graybill JR, Larsen RA (1998) Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis. Antimicrob Agents Chemother 42:528\u2013533","journal-title":"Antimicrob Agents Chemother"},{"key":"1034_CR22","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1128\/AAC.40.9.2178","volume":"40","author":"RA Larsen","year":"1996","unstructured":"Larsen RA, Bauer M, Weiner JM, Diamond DM, Leal MAE, Ding JC, Rinaldi MG, Graybill JR (1996) Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis. Antimicrob Agents Chemother 40:2178\u20132182","journal-title":"Antimicrob Agents Chemother"},{"key":"1034_CR23","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/AAC.00085-07","volume":"51","author":"WR Kirkpatrick","year":"2007","unstructured":"Kirkpatrick WR, Najvar LK, Bocanegra R, Patterson TF, Graybill JR (2007) New guinea pig model of cryptococcal meningitis. Antimicrob Agents Chemother 51:3011\u20133013","journal-title":"Antimicrob Agents Chemother"},{"key":"1034_CR24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1567-1364.2006.00128.x","volume":"7","author":"AMF Almeida","year":"2007","unstructured":"Almeida AMF, Matsumoto MT, Baeza LC, de Oliveira E Silva RB, Kleiner AAP, Melhem Mde SC, Mendes Giannini MJ; Laboratory Group on Cryptococcosis (2007) Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from S\u00e3o Paulo State, Brazil. FEMS Yeast Res 7:152\u2013164","journal-title":"FEMS Yeast Res"},{"key":"1034_CR25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1130-1406(08)70035-4","volume":"25","author":"E Alvarado-Ram\u00edrez","year":"2008","unstructured":"Alvarado-Ram\u00edrez E, Torres-Rodr\u00edguez JM, Sellart M, Vidotto V (2008) Laccase activity in Cryptococcus gattii strains isolated from goats. Rev Iberoam Micol 25:150\u2013153","journal-title":"Rev Iberoam Micol"},{"key":"1034_CR26","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/AAC.40.3.822","volume":"40","author":"SP Franzot","year":"1996","unstructured":"Franzot SP, Hamdan JS (1996) In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs. Antimicrob Agents Chemother 40:822\u2013824","journal-title":"Antimicrob Agents Chemother"},{"key":"1034_CR27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2958.2003.03281.x","volume":"47","author":"B Posteraro","year":"2003","unstructured":"Posteraro B, Sanguinetti M, Sanglard D, La Sorda M, Boccia S, Romano L, Morace G, Fadda G (2003) Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol Microbiol 47:357\u2013371","journal-title":"Mol Microbiol"},{"key":"1034_CR28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1567-1364.2008.00470.x","volume":"9","author":"CF Orsi","year":"2009","unstructured":"Orsi CF, Colombari B, Ardizzoni A, Peppoloni S, Neglia R, Posteraro B, Morace G, Fadda G, Blasi E (2009) The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation. FEMS Yeast Res 9:301\u2013310","journal-title":"FEMS Yeast Res"},{"key":"1034_CR29","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1086\/424746","volume":"39","author":"L Einsiedel","year":"2004","unstructured":"Einsiedel L, Gordon DL, Dyer JR (2004) Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman. Clin Infect Dis 39:e78\u2013e82","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1034-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-010-1034-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1034-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:19:57Z","timestamp":1591834797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-010-1034-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,28]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1034"],"URL":"https:\/\/doi.org\/10.1007\/s10096-010-1034-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,28]]}}}